Insight Into the Anti-staphylococcal Activity of JBC 1847 at Sub-Inhibitory Concentration

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Insight Into the Anti-staphylococcal Activity of JBC 1847 at Sub-Inhibitory Concentration. / Ronco, Troels; Kappel, Line H.; Aragao, Maria F.; Biagi, Niccolo; Svenningsen, Søren; Christensen, Jørn B.; Permin, Anders; Saaby, Lasse; Holmstrøm, Kim; Klitgaard, Janne K.; Sabat, Artur J.; Akkerboom, Viktoria; Monaco, Monica; Tinelli, Marco; Friedrich, Alexander W.; Jana, Bimal; Olsen, Rikke H.

In: Frontiers in Microbiology, Vol. 12, 786173, 2022.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Ronco, T, Kappel, LH, Aragao, MF, Biagi, N, Svenningsen, S, Christensen, JB, Permin, A, Saaby, L, Holmstrøm, K, Klitgaard, JK, Sabat, AJ, Akkerboom, V, Monaco, M, Tinelli, M, Friedrich, AW, Jana, B & Olsen, RH 2022, 'Insight Into the Anti-staphylococcal Activity of JBC 1847 at Sub-Inhibitory Concentration', Frontiers in Microbiology, vol. 12, 786173. https://doi.org/10.3389/fmicb.2021.786173

APA

Ronco, T., Kappel, L. H., Aragao, M. F., Biagi, N., Svenningsen, S., Christensen, J. B., Permin, A., Saaby, L., Holmstrøm, K., Klitgaard, J. K., Sabat, A. J., Akkerboom, V., Monaco, M., Tinelli, M., Friedrich, A. W., Jana, B., & Olsen, R. H. (2022). Insight Into the Anti-staphylococcal Activity of JBC 1847 at Sub-Inhibitory Concentration. Frontiers in Microbiology, 12, [786173]. https://doi.org/10.3389/fmicb.2021.786173

Vancouver

Ronco T, Kappel LH, Aragao MF, Biagi N, Svenningsen S, Christensen JB et al. Insight Into the Anti-staphylococcal Activity of JBC 1847 at Sub-Inhibitory Concentration. Frontiers in Microbiology. 2022;12. 786173. https://doi.org/10.3389/fmicb.2021.786173

Author

Ronco, Troels ; Kappel, Line H. ; Aragao, Maria F. ; Biagi, Niccolo ; Svenningsen, Søren ; Christensen, Jørn B. ; Permin, Anders ; Saaby, Lasse ; Holmstrøm, Kim ; Klitgaard, Janne K. ; Sabat, Artur J. ; Akkerboom, Viktoria ; Monaco, Monica ; Tinelli, Marco ; Friedrich, Alexander W. ; Jana, Bimal ; Olsen, Rikke H. / Insight Into the Anti-staphylococcal Activity of JBC 1847 at Sub-Inhibitory Concentration. In: Frontiers in Microbiology. 2022 ; Vol. 12.

Bibtex

@article{66daa29222a74171849f3c4679ee9243,
title = "Insight Into the Anti-staphylococcal Activity of JBC 1847 at Sub-Inhibitory Concentration",
abstract = "Multidrug-resistant pathogens constitute a serious global issue and, therefore, novel antimicrobials with new modes of action are urgently needed. Here, we investigated the effect of a phenothiazine derivative (JBC 1847) with high antimicrobial activity on Staphylococcus aureus, using a wide range of in vitro assays, flow cytometry, and RNA transcriptomics. The flow cytometry results showed that JBC 1847 rapidly caused depolarization of the cell membrane, while the macromolecule synthesis inhibition assay showed that the synthesis rates of DNA, RNA, cell wall, and proteins, respectively, were strongly decreased. Transcriptome analysis of S. aureus exposed to sub-inhibitory concentrations of JBC 1847 identified a total of 78 downregulated genes, whereas not a single gene was found to be significantly upregulated. Most importantly, there was downregulation of genes involved in adenosintrifosfat (ATP)-dependent pathways, including histidine biosynthesis, which is likely to correlate with the observed lower level of intracellular ATP in JBC 1847–treated cells. Furthermore, we showed that JBC 1847 is bactericidal against both exponentially growing cells and cells in a stationary growth phase. In conclusion, our results showed that the antimicrobial properties of JBC 1847 were primarily caused by depolarization of the cell membrane resulting in dissipation of the proton motive force (PMF), whereby many essential bacterial processes are affected. JBC 1847 resulted in lowered intracellular levels of ATP followed by decreased macromolecule synthesis rate and downregulation of genes essential for the amino acid metabolism in S. aureus. Bacterial compensatory mechanisms for this proposed multi-target activity of JBC 1847 seem to be limited based on the observed very low frequency of resistance toward the compound.",
keywords = "antimicrobial resistance, Gram-positive bacteria, mode of action, phenothiazine derivative, RNA transcriptomics",
author = "Troels Ronco and Kappel, {Line H.} and Aragao, {Maria F.} and Niccolo Biagi and S{\o}ren Svenningsen and Christensen, {J{\o}rn B.} and Anders Permin and Lasse Saaby and Kim Holmstr{\o}m and Klitgaard, {Janne K.} and Sabat, {Artur J.} and Viktoria Akkerboom and Monica Monaco and Marco Tinelli and Friedrich, {Alexander W.} and Bimal Jana and Olsen, {Rikke H.}",
note = "Publisher Copyright: Copyright {\textcopyright} 2022 Ronco, Kappel, Aragao, Biagi, Svenningsen, Christensen, Permin, Saaby, Holmstr{\o}m, Klitgaard, Sabat, Akkerboom, Monaco, Tinelli, Friedrich, Jana and Olsen.",
year = "2022",
doi = "10.3389/fmicb.2021.786173",
language = "English",
volume = "12",
journal = "Frontiers in Microbiology",
issn = "1664-302X",
publisher = "Frontiers Media S.A.",

}

RIS

TY - JOUR

T1 - Insight Into the Anti-staphylococcal Activity of JBC 1847 at Sub-Inhibitory Concentration

AU - Ronco, Troels

AU - Kappel, Line H.

AU - Aragao, Maria F.

AU - Biagi, Niccolo

AU - Svenningsen, Søren

AU - Christensen, Jørn B.

AU - Permin, Anders

AU - Saaby, Lasse

AU - Holmstrøm, Kim

AU - Klitgaard, Janne K.

AU - Sabat, Artur J.

AU - Akkerboom, Viktoria

AU - Monaco, Monica

AU - Tinelli, Marco

AU - Friedrich, Alexander W.

AU - Jana, Bimal

AU - Olsen, Rikke H.

N1 - Publisher Copyright: Copyright © 2022 Ronco, Kappel, Aragao, Biagi, Svenningsen, Christensen, Permin, Saaby, Holmstrøm, Klitgaard, Sabat, Akkerboom, Monaco, Tinelli, Friedrich, Jana and Olsen.

PY - 2022

Y1 - 2022

N2 - Multidrug-resistant pathogens constitute a serious global issue and, therefore, novel antimicrobials with new modes of action are urgently needed. Here, we investigated the effect of a phenothiazine derivative (JBC 1847) with high antimicrobial activity on Staphylococcus aureus, using a wide range of in vitro assays, flow cytometry, and RNA transcriptomics. The flow cytometry results showed that JBC 1847 rapidly caused depolarization of the cell membrane, while the macromolecule synthesis inhibition assay showed that the synthesis rates of DNA, RNA, cell wall, and proteins, respectively, were strongly decreased. Transcriptome analysis of S. aureus exposed to sub-inhibitory concentrations of JBC 1847 identified a total of 78 downregulated genes, whereas not a single gene was found to be significantly upregulated. Most importantly, there was downregulation of genes involved in adenosintrifosfat (ATP)-dependent pathways, including histidine biosynthesis, which is likely to correlate with the observed lower level of intracellular ATP in JBC 1847–treated cells. Furthermore, we showed that JBC 1847 is bactericidal against both exponentially growing cells and cells in a stationary growth phase. In conclusion, our results showed that the antimicrobial properties of JBC 1847 were primarily caused by depolarization of the cell membrane resulting in dissipation of the proton motive force (PMF), whereby many essential bacterial processes are affected. JBC 1847 resulted in lowered intracellular levels of ATP followed by decreased macromolecule synthesis rate and downregulation of genes essential for the amino acid metabolism in S. aureus. Bacterial compensatory mechanisms for this proposed multi-target activity of JBC 1847 seem to be limited based on the observed very low frequency of resistance toward the compound.

AB - Multidrug-resistant pathogens constitute a serious global issue and, therefore, novel antimicrobials with new modes of action are urgently needed. Here, we investigated the effect of a phenothiazine derivative (JBC 1847) with high antimicrobial activity on Staphylococcus aureus, using a wide range of in vitro assays, flow cytometry, and RNA transcriptomics. The flow cytometry results showed that JBC 1847 rapidly caused depolarization of the cell membrane, while the macromolecule synthesis inhibition assay showed that the synthesis rates of DNA, RNA, cell wall, and proteins, respectively, were strongly decreased. Transcriptome analysis of S. aureus exposed to sub-inhibitory concentrations of JBC 1847 identified a total of 78 downregulated genes, whereas not a single gene was found to be significantly upregulated. Most importantly, there was downregulation of genes involved in adenosintrifosfat (ATP)-dependent pathways, including histidine biosynthesis, which is likely to correlate with the observed lower level of intracellular ATP in JBC 1847–treated cells. Furthermore, we showed that JBC 1847 is bactericidal against both exponentially growing cells and cells in a stationary growth phase. In conclusion, our results showed that the antimicrobial properties of JBC 1847 were primarily caused by depolarization of the cell membrane resulting in dissipation of the proton motive force (PMF), whereby many essential bacterial processes are affected. JBC 1847 resulted in lowered intracellular levels of ATP followed by decreased macromolecule synthesis rate and downregulation of genes essential for the amino acid metabolism in S. aureus. Bacterial compensatory mechanisms for this proposed multi-target activity of JBC 1847 seem to be limited based on the observed very low frequency of resistance toward the compound.

KW - antimicrobial resistance

KW - Gram-positive bacteria

KW - mode of action

KW - phenothiazine derivative

KW - RNA transcriptomics

U2 - 10.3389/fmicb.2021.786173

DO - 10.3389/fmicb.2021.786173

M3 - Journal article

C2 - 35069485

AN - SCOPUS:85123106742

VL - 12

JO - Frontiers in Microbiology

JF - Frontiers in Microbiology

SN - 1664-302X

M1 - 786173

ER -

ID: 291222891